Dr. Andrew Hertler Talks About Current Treatments, Quality of Life for Women With Endometrial Cancer
By Dr. Andrew Hertler, Evolent, Rob Dillard - Last Updated: October 11, 2024Dr. Andrew Hertler, Chief Medical Officer of Evolent, spoke with DocWire News about the biggest challenges associated with treating patients with endometrial cancer. Dr. Hertler also discussed how endometrial cancer impacts patient quality of life, and detailed the current treatment landscape in endometrial cancer care.
Advertisement
Advertisement
Related Posts
The global burden of cervical cancer, as well as cervical cancer mortality, is predicted to increase substantially by 2030.
A team of researchers aimed to analyze the genetic expression and prognostic value of selenoprotein gene mutations.
Based on these results, a three-diode laser vaginal session enhances and favors the complete closure of VVFs.
Deep learning algorithms combined with MRI could have a major impact on diagnosing patients with high-risk disease.
A Mendelian randomized analysis was performed to determine the effects of anti-CD20 antibodies on endometrial cancer.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.